App is temporarily unavailable
Description
医助通是一款以生产健康科普内容为主的医生工具型APP。医生通过视频、语音、问答等形式，进行科普内容生产，借助互联网开展健康科普工作，实现知识变现。APP中提供的“患者问卷调研”、“录制门诊常见问题”两大特色功能，可一定程度减少医患沟通成本，高效出诊。
Screenshots
医助通 FAQ
-
Is 医助通 free?
Yes, 医助通 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 医助通 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 医助通 cost?
医助通 is free.
-
What is 医助通 revenue?
To get estimated revenue of 医助通 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in South Africa yet.
Ratings History
医助通 Reviews
医助通 Installs
Last 30 days
医助通 Revenue
Last 30 days医助通 Revenue and Downloads
Gain valuable insights into 医助通 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Utilities
- Publisher
- Jiangsu Minfukang Technology Co
- Languages
- Chinese
- Recent release
- 1.4.2 (3 years ago )
- Released on
- Oct 8, 2020 (4 years ago )
- Also available in
- China , Poland , Japan , South Korea , Kuwait , Kazakhstan , Mexico , Malaysia , Nigeria , Netherlands , Norway , New Zealand , Peru , Philippines , Pakistan , India , Portugal , Romania , Russia , Saudi Arabia , Sweden , Singapore , Thailand , Türkiye , Ukraine , United States , Vietnam , South Africa , Algeria , Austria , Australia , Azerbaijan , Belgium , Brazil , Belarus , Switzerland , Chile , Colombia , Czechia , Germany , Denmark , Dominican Republic , Italy , Ecuador , Egypt , Spain , Finland , France , United Kingdom , Greece , Hungary , Indonesia , Ireland , Israel , United Arab Emirates
- Last Updated
- 1 year ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.